CPIX
Cumberland Pharmaceuticals Inc
7.10$
-4.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -15.9% | -305.4% | – | – | +300.5% | +104.7% | -78.4% | -77.8% | -98.4% | +12,698.4% | -56.4% | – | |
| – | +39.1% | -30.6% | -0.8% | -1.6% | +27.1% | -26.1% | +0.2% | +0.3% | +0.3% | +17.7% | -164.6% | – | |
| – | +13.0% | -16.1% | -8.6% | +6.1% | -2.0% | -0.8% | +8.7% | +0.7% | +111.9% | -37.9% | -27.1% | – | |
| – | +45.8% | -163.6% | – | – | -1.5% | -53.5% | -77.2% | +214.6% | -103.7% | – | -25.1% | – | |
| – | -8.8% | -32.9% | -19.6% | -12.8% | -34.3% | +77.7% | -44.4% | +21.7% | +36.0% | -100.0% | +35,619,080.0% | – | |
| – | – | -122.3% | -19.6% | – | -114.1% | +4,481.2% | – | -341.7% | +344.9% | -98.0% | +3,049.1% | – | |
| – | -6.3% | +31.0% | -45.8% | -26.4% | -0.4% | +149.9% | -97.1% | +45.6% | – | -123.2% | +0.0% | – | |
| – | – | – | – | – | – | +1,130.7% | -100.0% | – | – | – | – | – | |
| – | +68.5% | – | -112.8% | +73.4% | +156.8% | +300.9% | -97.3% | +156.6% | +76.2% | +12.0% | +605.8% | – | |
| – | -172.0% | – | -634.3% | – | +289.2% | -671.8% | – | -191.0% | – | – | – | – | |
| – | -16.5% | -330.2% | – | – | +263.7% | +105.1% | -78.8% | -81.0% | -126.3% | – | -516.6% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.